Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 14, 2015
Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?H J Park, K Kim, J H Paik, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2017
First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumorsY J Bang, G Giaccone, S A Im, et al.
Human Gene Therapy|October 6, 1998
Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancerD S Heo, S J Yoon, W S Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2019
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001A T Shaw, G J Riely, Y-J Bang, et al.
British Journal of Cancer|January 8, 2009
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancerS-W Han, D-Y Oh, S-A Im, et al.
British Journal of Cancer|November 13, 2008
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectivesJ W Kim, S-J Kim, Y-H Chung, et al.
British Journal of Cancer|March 5, 2009
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survivalJ-S Kim, M-A Kim, T M Kim, et al.
International Journal of Cancer|February 7, 1997
Establishment and characterization of human gastric carcinoma cell linesJ G Park, H K Yang, W H Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2021
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinomaK Shitara, M Özgüroğlu, Y-J Bang, et al.
British Journal of Cancer|February 20, 2008
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancerD-W Kim, H S Min, K-H Lee, et al.
Pageof 10